Why Shares of Intra-Cellular Therapies Inc Skyrocketed in September

Great clinical news on the company's lead compound sends shares screaming higher.

Brian Feroldi
Brian Feroldi
Oct 10, 2015 at 8:01AM
Health Care

Intra-Cellular Therapies (NASDAQ:ITCI) treated its investors to a great month, as shares of the biotech stock shot higher after the company released great clinical news. Get all the details in the following slideshow.